Protalix Biotherapeutics Inc (PLX)
Investing Cash Flow
-$1.03M
TTM · Period ending: · USD
PLX Investing Cash Flow
Latest reported-$1.03Mperiod ending
Latest reported-$1.03Mperiod ending
PLX TTM Cash from Investing (-$50.00K → -$1.03M)
TTM investing cash flow
High-resolution chart · PNG
PLX investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -1,028,000 | |
| 2,169,000 | |
| -2,366,000 | |
| -16,574,000 | |
| 4,257,000 | |
| 4,515,000 | |
| 4,221,000 | |
| 19,199,000 | |
| -22,007,000 | |
| -22,049,000 | |
| -16,711,000 | |
| -11,416,000 | |
| 15,375,000 | |
| 15,954,000 | |
| -5,035,000 | |
| 27,448,000 | |
| 26,165,000 | |
| 33,348,000 | |
| 18,921,000 | |
| -10,923,000 | |
| -7,749,000 | |
| -15,557,000 | |
| -19,952,000 | |
| -27,515,000 | |
| -35,764,000 | |
| -35,591,000 | |
| -883,000 | |
| -828,000 | |
| -610,000 | |
| -634,000 | |
| -591,000 | |
| -709,000 | |
| -597,000 | |
| -1,164,000 | |
| -1,119,000 | |
| -1,327,000 | |
| -1,277,000 | |
| -957,000 | |
| -967,000 | |
| 39,178,000 | |
| 39,075,000 | |
| 39,193,000 | |
| 39,387,000 | |
| -685,000 | |
| -783,000 | |
| -730,000 | |
| -1,001,000 | |
| -1,103,000 | |
| -1,255,000 | |
| -1,783,000 | |
| -2,102,000 | |
| -2,207,000 | |
| -2,607,000 | |
| -2,123,000 | |
| -2,286,000 | |
| -2,657,000 | |
| -2,866,000 | |
| -4,070,000 | |
| -5,868,000 | |
| -6,196,000 | |
| -6,552,000 | |
| -7,639,000 | |
| -7,992,000 | |
| -7,458,000 | |
| -7,515,000 | |
| -7,913,000 | |
| -6,174,000 | |
| -6,393,000 | |
| -5,908,000 | |
| -4,109,000 | |
| -3,701,000 | |
| -4,242,000 | |
| -3,579,000 | |
| -2,760,000 | |
| -2,438,000 | |
| -2,117,000 | |
| -1,824,000 | |
| -1,514,000 | |
| -980,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 552,359 | |
| 552,359 | |
| 0 | |
| 0 | |
| -552,359 | |
| -491,478 | |
| 71,166 | |
| 80,704 | |
| 90,088 | |
| 38,590 | |
| 1,336,571 | |
| 1,347,261 | |
| 1,292,587 | |
| 1,314,324 | |
| -118,740 |